| 标题 |
A multicenter, open-label, phase I/II study of IBI130, a TROP2-targeting antibody–drug conjugate, as monotherapy in patients with recurrent or metastatic cervical cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Gynecologic Oncology 作者:Qin Xu; Xingyun Xie; Yuting Shi; Yaxin Kang; Huaqin Lin; et al 出版日期:2026-04-23 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)